Global Pregnant Mare Serum Gonadotropin (PMSG) Competitive Landscape Professional Research Report 2025

Research Summary

Pregnant Mare Serum Gonadotropin (PMSG), also known as equine chorionic gonadotropin (eCG), is a hormone extracted from the blood serum of pregnant mares. It is a glycoprotein hormone that plays a critical role in the reproductive processes of horses and other mammals. PMSG is commonly used in veterinary medicine and animal breeding to stimulate ovarian follicle development and induce ovulation in various species, such as cattle, sheep, and pigs. It mimics the action of follicle-stimulating hormone (FSH) in animals, promoting the growth and maturation of eggs in the ovaries, and is often used in combination with other hormones for synchronized breeding programs. PMSG is also employed in livestock production to enhance fertility rates and improve the efficiency of artificial insemination techniques. While its primary application is in animal reproduction, PMSG has also been used in research related to human fertility and hormone therapy. However, its use has raised some ethical concerns regarding animal welfare in the context of hormone extraction and application.

According to DIResearch's in-depth investigation and research, the global Pregnant Mare Serum Gonadotropin (PMSG) market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of Pregnant Mare Serum Gonadotropin (PMSG) include MSD Animal Health, Ceva Santé Animale, Syntex SA, Bioveta, Ningbo Sansheng Biological Technology, Ningbo Second Hormone Factory, Chifeng Bo-en Pharmaceutical, Guangzhou Vbio-Pharma, JALLY, Ningbo Creator Animal Pharmaceutical etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Pregnant Mare Serum Gonadotropin (PMSG). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Pregnant Mare Serum Gonadotropin (PMSG) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Pregnant Mare Serum Gonadotropin (PMSG) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Pregnant Mare Serum Gonadotropin (PMSG) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Pregnant Mare Serum Gonadotropin (PMSG) Include:

MSD Animal Health

Ceva Santé Animale

Syntex SA

Bioveta

Ningbo Sansheng Biological Technology

Ningbo Second Hormone Factory

Chifeng Bo-en Pharmaceutical

Guangzhou Vbio-Pharma

JALLY

Ningbo Creator Animal Pharmaceutical

Pregnant Mare Serum Gonadotropin (PMSG) Product Segment Include:

1000 IU/Unit

5000 IU/Unit

Others

Pregnant Mare Serum Gonadotropin (PMSG) Product Application Include:

Pig

Cattle

Sheep

Horse

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Pregnant Mare Serum Gonadotropin (PMSG) Industry PESTEL Analysis

Chapter 3: Global Pregnant Mare Serum Gonadotropin (PMSG) Industry Porter’s Five Forces Analysis

Chapter 4: Global Pregnant Mare Serum Gonadotropin (PMSG) Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Pregnant Mare Serum Gonadotropin (PMSG) Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Pregnant Mare Serum Gonadotropin (PMSG) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Pregnant Mare Serum Gonadotropin (PMSG) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Pregnant Mare Serum Gonadotropin (PMSG) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Pregnant Mare Serum Gonadotropin (PMSG) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Pregnant Mare Serum Gonadotropin (PMSG) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Pregnant Mare Serum Gonadotropin (PMSG) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Pregnant Mare Serum Gonadotropin (PMSG) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources